InMed shareholders elect all director nominees and appoint Marcum LLP as auditor at 2022 AGM

InMed Pharmaceuticals Inc.

All five director nominees elected: Eric A. Adams (94.90%), Andrew Hull (94.34%), Janet Grove (96.70%), Bryan Baldasare (95.82%), Nicole Lemerond (96.66%).
Marcum LLP appointed as independent registered public accounting firm with 97.68% votes in favor.
All proposals approved by shareholders at December 15, 2022 annual meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

InMed Pharmaceuticals Inc. shareholders approved Appointment of Independent Registered Public Accounting Firm at the 2022-12-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2022-12-15

Exact text from the filing

Proposal No. 2—Appointment of Independent Registered Public Accounting Firm The Corporation’s shareholders voted to approve the appointment of Marcum LLP as the independent registered public accounting firm of the Corporation until the 2023 Annual General Meeting of Shareholders or until a successor is named. Votes For % Votes For Vote Against % Votes Against Abstain Broker Non-Votes 339,548 97,68% 0 0% 8,047 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

InMed Pharmaceuticals Inc. shareholders approved Election of Directors at the 2022-12-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2022-12-15

Exact text from the filing

Proposal No. 1—Election of Directors The Corporation’s shareholders voted to elect the following persons to the board of directors of the Corporation, each to serve until the 2023 Annual General Meeting of Shareholders: Nominee Votes For % Votes For Votes Withheld % Votes Withheld Broker Non-Votes Eric A. Adams 159,223 94.90 % 8,559 5.10 % 179,813 Andrew Hull 158,282 94.34 % 9,500 5.66 % 179,813 Janet Grove 162,246 96.70 % 5,536 3.30 % 179,813 Bryan Baldasare 160,764 95.82 % 7,018 4.18 % 179,813 Nicole Lemerond 162,174 96.66 % 5,608 3.34 % 179,813

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

InMed Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-080602

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.